Ashley Davis, FNP

NPI: 1396230504
Total Payments
$2,308
2024 Payments
$1,016
Companies
22
Transactions
121
Medicare Patients
3,078
Medicare Billing
$198,352

Payment Breakdown by Category

Food & Beverage$2,308 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,308 121 100.0%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $567.21 37 $0 (2024)
Merck Sharp & Dohme LLC $318.82 18 $0 (2024)
Merz North America, Inc. $253.75 2 $0 (2022)
Kestra Medical Technology Services, Inc. $169.21 9 $0 (2024)
AstraZeneca Pharmaceuticals LP $108.97 7 $0 (2024)
Janssen Pharmaceuticals, Inc $108.45 6 $0 (2024)
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $101.95 6 $0 (2024)
PFIZER INC. $101.12 5 $0 (2024)
Amgen Inc. $100.40 6 $0 (2024)
E.R. Squibb & Sons, L.L.C. $71.09 5 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,016 59 Novartis Pharmaceuticals Corporation ($283.29)
2023 $720.37 40 Novartis Pharmaceuticals Corporation ($205.74)
2022 $571.58 22 Merz North America, Inc. ($253.75)

All Payment Transactions

121 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
12/12/2024 Kestra Medical Technology Services, Inc. Assure WCD (Device) Food and Beverage Cash or cash equivalent $12.20 General
Category: Cardiology
12/11/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $2.33 General
Category: Cardiology/Vascular Diseases
12/10/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $16.06 General
Category: CARDIOVASCULAR
12/05/2024 Boston Scientific Corporation Varithena Administration Pack (Device) Food and Beverage In-kind items and services $20.26 General
Category: Varithena_PI
12/04/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $19.41 General
Category: Cardiology/Vascular Diseases
12/03/2024 Philips North America LLC (CK4) MCOT (Device) Food and Beverage Cash or cash equivalent $14.53 General
Category: Medical Device
11/26/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $16.58 General
Category: Cardiology
11/12/2024 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $25.07 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
11/07/2024 Kestra Medical Technology Services, Inc. Assure WCD (Device) Food and Beverage Cash or cash equivalent $21.57 General
Category: Cardiology
10/28/2024 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $17.07 General
Category: Electromedical and Electrotherapeutic Apparatus
10/23/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $18.65 General
Category: Cardiology/Vascular Diseases
10/21/2024 Kestra Medical Technology Services, Inc. Assure WCD (Device) Food and Beverage Cash or cash equivalent $22.82 General
Category: Cardiology
10/19/2024 Boston Scientific Corporation WATCHMAN FLX (Device) Food and Beverage In-kind items and services $33.44 General
Category: WATCHMAN FLX_IC
10/15/2024 Kestra Medical Technology Services, Inc. Assure WCD (Device) Food and Beverage Cash or cash equivalent $17.50 General
Category: Cardiology
10/14/2024 Philips North America LLC (CK4) MCOT (Device) Food and Beverage Cash or cash equivalent $24.05 General
Category: Medical Device
10/02/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $14.47 General
Category: Cardiology
10/01/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $15.27 General
Category: Cardiology
09/30/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $9.00 General
Category: Cardiology/Vascular Diseases
09/19/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $14.84 General
Category: Cardiology
09/18/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $20.35 General
Category: CARDIOVASCULAR
09/11/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $12.55 General
Category: Cardiology/Vascular Diseases
09/11/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $1.13 General
Category: Cardiology/Vascular Diseases
09/04/2024 Kestra Medical Technology Services, Inc. Assure WCD (Device) Food and Beverage Cash or cash equivalent $20.26 General
Category: Cardiology
08/28/2024 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $6.39 General
Category: Electromedical and Electrotherapeutic Apparatus
08/01/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $23.01 General
Category: CARDIOVASCULAR

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 1,068 1,796 $173,943 $58,943
2022 13 1,411 2,243 $273,971 $94,219
2021 5 599 726 $170,385 $45,190
Total Patients
3,078
Total Services
4,765
Medicare Billing
$198,352
Procedure Codes
27

All Medicare Procedures & Services

27 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 453 524 $81,224 $28,367 34.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 214 262 $63,086 $19,842 31.5%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 66 66 $10,300 $4,234 41.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 41 41 $10,318 $4,016 38.9%
96372 Injection of drug or substance under skin or into muscle Office 2023 93 126 $3,780 $1,037 27.4%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 79 82 $2,378 $679.16 28.6%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 18 18 $1,620 $604.42 37.3%
J0696 Injection, ceftriaxone sodium, per 250 mg Office 2023 71 373 $932.50 $139.66 15.0%
J1100 Injection, dexamethasone sodium phosphate, 1 mg Office 2023 33 304 $304.00 $22.64 7.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 372 543 $137,498 $45,274 32.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 495 609 $100,218 $35,100 35.0%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 55 55 $8,756 $4,370 49.9%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 29 29 $6,888 $3,225 46.8%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 45 50 $5,745 $1,850 32.2%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 191 208 $6,251 $1,825 29.2%
16020 Dressing change or removal of burn tissue, less than 5% of total body surface Office 2022 17 22 $3,850 $1,260 32.7%
96372 Injection of drug or substance under skin or into muscle Office 2022 78 94 $2,820 $888.15 31.5%
96360 Infusion into a vein for hydration, 31-60 minutes Office 2022 11 11 $825.00 $248.49 30.1%
J0696 Injection, ceftriaxone sodium, per 250 mg Office 2022 45 239 $597.50 $95.15 15.9%
J1885 Injection, ketorolac tromethamine, per 15 mg Office 2022 26 65 $162.50 $32.71 20.1%
J1100 Injection, dexamethasone sodium phosphate, 1 mg Office 2022 36 297 $297.00 $28.50 9.6%
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) Office 2022 11 21 $63.00 $22.27 35.3%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 330 413 $77,644 $25,808 33.2%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 138 173 $46,018 $15,372 33.4%
99285 Emergency department visit, problem with significant threat to life or function Facility 2021 17 17 $41,650 $2,340 5.6%

About Ashley Davis, FNP

Ashley Davis, FNP is a Nurse Practitioner healthcare provider based in Summerfield, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2018. The National Provider Identifier (NPI) number assigned to this provider is 1396230504.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ashley Davis, FNP has received a total of $2,308 in payments from pharmaceutical and medical device companies, with $1,016 received in 2024. These payments were reported across 121 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,308).

As a Medicare-enrolled provider, Davis has provided services to 3,078 Medicare beneficiaries, totaling 4,765 services with total Medicare billing of $198,352. Data is available for 3 years (2021–2023), covering 27 distinct procedure/service records.

Practice Information

  • Specialty Nurse Practitioner
  • Location Summerfield, FL
  • Active Since 06/29/2018
  • Last Updated 05/02/2025
  • Taxonomy Code 363L00000X
  • Entity Type Individual
  • NPI Number 1396230504

Products in Payments

  • LEQVIO (Drug) $473.17
  • VERQUVO (Drug) $318.82
  • Xeomin (Biological) $253.75
  • Assure WCD (Device) $169.21
  • ELIQUIS (Drug) $151.20
  • XARELTO (Drug) $108.45
  • LifeVest (Device) $101.95
  • Repatha (Biological) $100.40
  • ENTRESTO (Drug) $94.04
  • BRILINTA (Drug) $93.21
  • Kerendia (Drug) $65.12
  • Inpefa (Drug) $40.84
  • (CK4) MCOT (Device) $38.58
  • NEXLETOL (Drug) $34.07
  • WATCHMAN FLX (Device) $33.44
  • JARDIANCE (Drug) $29.09
  • INJECTAFER (Drug) $24.65
  • Vascepa (Drug) $23.27
  • PAXLOVID (Drug) $21.01
  • Varithena Administration Pack (Device) $20.26

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nurse Practitioner Doctors in Summerfield